Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription


1 Int J Neurosci
1 J Neurochem
6 Mov Disord
1 Nat Rev Neurol
1 Nervenarzt
1 Neurologia (Engl Ed)
1 Neurology
1 PLoS One
1 Science

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Int J Neurosci

  1. MOHAMAD NAJIB NH, Yahaya MF, Das S, Teoh SL, et al
    The Effects of Metallothionein in Paraquat-induced Parkinson Disease Model of Zebrafish.
    Int J Neurosci. 2021 Oct 8:1-13. doi: 10.1080/00207454.2021.1990916.
    PubMed         Abstract available

    J Neurochem

  2. LEE CY, Menozzi E, Chau KY, Schapira AHV, et al
    Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genes.
    J Neurochem. 2021 Oct 7. doi: 10.1111/jnc.15524.
    PubMed         Abstract available

    Mov Disord

  3. GULER S, Gul T, Guler S, Haerle MC, et al
    Early-Onset Parkinson's Disease: A Novel Deletion Comprising the DJ-1 and TNFRSF9 Genes.
    Mov Disord. 2021 Oct 3. doi: 10.1002/mds.28812.
    PubMed         Abstract available

  4. JUCAITE A, Cselenyi Z, Kreisl WC, Rabiner EA, et al
    Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [(11) C]PBR28 and Machine Learning Analysis.
    Mov Disord. 2021 Oct 5. doi: 10.1002/mds.28814.
    PubMed         Abstract available

  5. PIHLSTROM L, Fan CC, Frei O, Tan M, et al
    Genetic Stratification of Age-Dependent Parkinson's Disease Risk by Polygenic Hazard Score.
    Mov Disord. 2021 Oct 6. doi: 10.1002/mds.28808.
    PubMed         Abstract available

  6. PU JL, Jin CY, Wang ZX, Fang Y, et al
    Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's Disease.
    Mov Disord. 2021 Oct 6. doi: 10.1002/mds.28805.
    PubMed         Abstract available

  7. MAGRINELLI F, Mehta S, Di Lazzaro G, Latorre A, et al
    Dissecting the Phenotype and Genotype of PLA2G6-Related Parkinsonism.
    Mov Disord. 2021 Oct 8. doi: 10.1002/mds.28807.
    PubMed         Abstract available

  8. SCHIRINZI T, Maftei D, Ralli M, Greco A, et al
    Serum Substance P Is Increased in Parkinson's Disease and Correlates with Motor Impairment.
    Mov Disord. 2021 Oct 8. doi: 10.1002/mds.28824.

    Nat Rev Neurol

  9. MAETZLER W, Pilotto A
    Digital assessment at home - mPower against Parkinson disease.
    Nat Rev Neurol. 2021 Oct 5. pii: 10.1038/s41582-021-00567.


  10. WAGNER L, Deck R
    [Implementation of an individualized tablet-based training program in the domestic setting following complex treatment of Parkinson's disease-Success factors and barriers].
    Nervenarzt. 2021 Oct 7. pii: 10.1007/s00115-021-01202.
    PubMed         Abstract available

    Neurologia (Engl Ed)

  11. LUIZ LMD, Marques IA, Folador JP, Andrade AO, et al
    Intra and inter-rater remote assessment of bradykinesia in Parkinson's disease.
    Neurologia (Engl Ed). 2021 Sep 16. pii: S0213-4853(21)00130.
    PubMed         Abstract available


  12. RUSZ J, Tykalova T, Novotny M, Zogala D, et al
    Defining Speech Subtypes in De Novo Parkinson Disease: Response to Long-term Levodopa Therapy.
    Neurology. 2021 Oct 4. pii: WNL.0000000000012878.
    PubMed         Abstract available

    PLoS One

  13. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    PLoS One. 2021;16:e0257372.
    PubMed         Abstract available


  14. HAAS CA
    Revisiting brain stimulation in Parkinson's disease.
    Science. 2021;374:153-154.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.